GlobalData on MSN
Everest Medicines and Micot partner on MT1013 commercialisation
Everest Medicines expects the partnership to complement its renal pipeline and broaden its nephrology product range.
Vietnam Investment Review on MSN
Everest Medicines licenses MT1013 from Micot
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results